Importance of 5-FU-based adjuvant Chemotherapy after preoperative Radio Chemo Threapy in locally advanced Rectal Cancer 10-Year results of the EORTC-22921-Study

被引：1
|
作者：
Guckenberger, Matthias [1 ]
机构：
[1] Univ Hosp Zurich USZ, Dept Radiat Oncol, CH-8091 Zurich, Switzerland
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2014年 / 190卷 / 08期
关键词：
PHASE-III TRIAL; POSTOPERATIVE CHEMORADIOTHERAPY; COLON; CAO/ARO/AIO-94; FLUOROURACIL; OXALIPLATIN; SURVIVAL; THERAPY;
D O I：
10.1007/s00066-014-0699-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：772 / 773
页数：2
相关论文
共 40 条
  • [21] A phase II open-label prospective study of preoperative chemoradiation with oxaliplatin/5FU in locally advanced rectal cancer followed by total mesorectal excision and adjuvant FOLFOX6.
    Siu, K.
    Young, R.
    Kozuch, P.
    Mirzoyev, T.
    Rosenwald, V.
    Francois, D.
    Cohen, S. M.
    Hu, K.
    Grossbard, M. L.
    Malamud, S. C.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [22] The Impact of Chemosensitivity to 5-Fluorouracil based Preoperative Chemoradiotherapy in Locally Advanced Rectal Cancer: A study using in vitro adenosine triphosphate-based chemotherapy response assay
    Jeon, Youngbae
    Lee, Hae-Won
    Park, Eun Jung
    Kang, Jeonghyun
    Baik, Fascrs Seung Hyuk
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 458 - 458
  • [23] Capecitabine (Cape) versus 5-fluorouracil (5-FU)-based (neo-)adjuvant chemoradiotherapy (CRT) for locally advanced rectal cancer (LARC): Safety results of a randomized, phase III trial
    Hofheinz, R.
    Wenz, F.
    Post, S.
    Matzdorff, A.
    Laechelt, S.
    Mueller, L.
    Link, H.
    Moehler, M.
    Burkholder, I.
    Hochhaus, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [24] Adjuvant chemotherapy with oxaliplatin/5-fluorouracil/leucovorin (FOLFOX) versus 5-fluorouracil/leucovorin (FL) in patients with locally advanced rectal cancer after preoperative chemoradiotherapy followed by surgery: A randomized phase II study (The ADORE)
    Hong, Yong Sang
    Nam, Byung-Ho
    Jung, Kyung Hae
    Lee, Jae-Lyun
    Kim, Kyu-Pyo
    Park, Young Suk
    Park, Joon Oh
    Kim, Sun Young
    Kim, Tae-You
    Kim, Jee Hyun
    Ahn, Joong Bae
    Kim, Tae Won
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [25] Capecitabine (Cape) versus 5-fluorouracil (5-FU)-based (neo) adjuvant chemoradiotherapy (CRT) for locally advanced rectal cancer (LARC): Long-term results of a randomized, phase III trial
    Hofheinz, R.
    Wenz, F. K.
    Post, S.
    Matzdorff, A.
    Laechelt, S.
    Hartmann, J. T.
    Mueller, L.
    Link, H.
    Moehler, M. H.
    Kettner, E.
    Fritz, E.
    Hieber, U.
    Lindemann, H. W.
    Grunewald, M.
    Kremers, S.
    Constantin, C.
    Hipp, M.
    Gencer, D.
    Burkholder, I.
    Hochhaus, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [26] Irinatecan (CPT-11) and 5-fluorouracil (5-FU) concomitantly with preoperative radiotherapy (RT) in patients (pts) with locally advanced resectable rectal cancer.: Updated results of a phase II study
    Dotor, E
    Navarro, M
    Vega, ME
    Sánchez-Rovira, P
    Cervantes, A
    García, JL
    Suárez, M
    Aranda, E
    Asensio, D
    García, A
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 358S - 358S
  • [27] TREATMENT OF LOCALLY ADVANCED BREAST-CANCER WITHOUT MASTECTOMY - 5-YEAR AND 10-YEAR RESULTS OF 135 TUMORS LARGER THAN 5 CENTIMETERS TREATED BY EXTERNAL-BEAM THERAPY, BRACHYTHERAPY, AND NEOADJUVANT CHEMOTHERAPY
    BAILLET, F
    ROZEC, C
    UCLA, L
    CHAUVEINC, L
    HOUSSET, M
    WEIL, M
    BREAST CANCER: FROM BIOLOGY TO THERAPY, 1993, 698 : 264 - 270
  • [28] Preoperative chemotherapy and concurrent radio-chemotherapy followed by definitive surgery ("Trimodality") in patients with locally advanced inoperable non-small-cell lung cancer stage IIIA/IIIB -: 10-year-survival results
    Gauler, T
    Sailer, V
    Pöttgen, C
    Korfee, S
    Krbek, T
    Stamatis, G
    Wilke, H
    Seeber, S
    Stuschke, M
    Eberhardt, W
    LUNG CANCER, 2005, 49 : S14 - S14
  • [29] THE INFLUENCE OF CHEMOSENSITIVITY FOR 5-FLUOROURACIL AFTER PREOPERATIVE CHEMORADIOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED RECTAL CANCER USING IN VITRO ADENOSINE TRIPHOSPHATE-BASED CHEMOTHERAPY RESPONSE ASSAY.
    Jun, S.
    Jeon, Y.
    Park, E.
    Kang, J.
    Baik, S.
    DISEASES OF THE COLON & RECTUM, 2019, 62 (06) : E317 - E317
  • [30] Clinical predictive value of in vitro anticancer drug sensitivity test for the therapeutic effect of 5-FU based adjuvant chemotherapy in patients with stage II-III colorectal cancer: 10-year follow up results.
    Sonoda, Hiromichi
    Mekata, Eiji
    Shimizu, Tomoharu
    Miyake, Toru
    Ueki, Tomoyuki
    Mori, Tsuyoshi
    Tani, Masaji
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
1234